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Abstract
In recent years, colloidal semiconductor nanocrystals, commonly known as quantum dots, have gained much attention in fields such as materials chemistry, bioengineering, chemical and biomedical engineering. These
semiconductor nanocrystals display unique optical, electrical, and chemical properties unlike any bulk material or individual molecule. Areas of particular interest in the field of quantum dots include biofunctionalization.
Advances in biology and medicine indicate successful bioconjugate functionalization of biomolecules such as peptides, antibodies, nucleic acids, or small-molecules for labeling and intracellular tracking. This research is focused on
the multistep synthesis of CdSe/CdS core-shell nanoparticles as well as employment of two different solubilization methods—lipid encapsulation and ligand exchange with mercapto-carboxylic acids. The synthesis begins by
synthesizing the CdSe core using CdO and Se as precursors. Two layers of CdS shells are then applied over the core with cadmium and sulfur. The quantum dot is then made water soluble by encapsulating the hydrophobic particle
in a micelle using phospholipid encapsulation method or by using ligand-exchange method using 3-mercaptopropionic acid. Once water soluble, specific oligonucleotides (DNA) are then functionalized to the quantum dots.

Results & Discussion

Materials & Methods

Quantum dots involve a multi-step synthesis to
produce the core and shell of the fluorescent particle.
For core synthesis, CdO and Se precursors are
injected and mixed to yield a nanoparticle of desired
size. The size and fluorescence emission wavelength
of the nanocrystal is a function of the time and
temperature of the reaction. To enhance particle
fluorescence, CdS shells are applied over the core.
Depending on the final destination of the hydrophobic
particle, another step may be necessary to render it
soluble in hydrophilic media, as is the case for
biomolecular conjugation and biomedical imaging. To
yield a water-soluble particle, two methods may be
employed: lipid encapsulation with DSPE-PEG(2000)
Maleimide (GMP) ( Figure 1) or ligand exchange with
3-mercaptopropionic acid . Once a stable watersoluble quantum dot is produced, they may be
functionalized to various small molecules, or
biomolecules such as DNA, proteins, or antibodies.
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Figure 3: Full spectrum of CdSe/CdS core/shell quantum
dot solutions from ~500-630 nm.

Figure 4: UV spectra scan of CdSe/CdS core/shell spectrum
(Figure 2) displaying relationship of color to size.

Fluorescence Emission of CdSe-CdS Core-Shell

CdSe Core and CdSe/CdS Core/Shell Fluorometry Analysis
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Figure 1: DSPE-PEG(2000) Maleimide (GMP) used in lipid
encapsulation for water solubilization-- 1,2-distearoyl-snglycero-3-phosphoethanolamine-N-[maleimide(polyethylene
glycol)2000] (ammonium salt).
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Figure 2: 3-D
representation
of CdSe core,
CdS shell, and
functional
lipid/ligand
water soluble
layer. (Ref 5)
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•Step 1– Core Synthesis: Selenium and trioctylphosphine
dissolved in 1-Octadecene precursor and rapidly injected
into cadmium oxide/oleic acid/1-octadecene precursor.
Temperature is adjusted to yield desired size of
nanocrystal.(Ref 4)
•Step 2– Shell Synthesis: Cadmium oxide/oleic acid and
sulfur precursors are individually prepared in 1-Octadecene
and added drop wise to the core solution.(Ref 4)
•Step 3– Water Solubilization: Hydrophobic core/shell
particles can be made hydrophilic via encapsulation with
DSPE-PEG(2000) Maleimide or ligand exchange with 3Mercaptopropionic
acid.
Deprotonation
of
3Mercaptopropionic acid with DMAP creates a charged and
hydrophilic particle.(Ref 1, 2, 3)
•Step 4– DNA Functionalization: DNA with a functional
thiol can be functionalized directly to the maleimide moiety
in the lipid procedure or by ligand exchange with 3Mercaptopropionic acid.(Ref 1)

Figure 5. Fluorometry scan of CdSe/CdS core/shell
spectrum (Figure 3) at excitation wavelength of 365 nm.
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Figure 6. Fluorometry scan of individual core and core-shell
particles at excitation wavelength of 365 nm.

Future Works
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• Optimization of core and core/shell synthesis for
specific temperature dependent particle diameter.
• Optimization of precursor concentrations for
streamlined core and core/shell synthesis.
• Optimization
of
quantum
dot
water
solubilization using both 3-Mecaptopropionic acid
and phospholipids.
• Assembly of quantum dots using DNA origami as
a
template
or
co-assembly
with
metal
nanoparticles for investigation of optical and
electrical properties.

1. Mitchell, G. P.; Mirkin, C. A.; Letsinger, R. L. J. Am. Chem.
Soc. 1999, 121, 8122-8123.
2. Srinivasan, C.; Lee, J.; Papadimitrakopoulos, F.; Silbart, L.
K.; Zhao, M.; Burgess, D. J. Molecular Therapy. 2006, 14,
192-201.
3. Dubertret, B.; Skourides, P.; Norris, D. J.; Noireaux, V.;
Brivanlou, A. H.; Libchaber, A. Science, 2002, 202, 17591762.
4. Li, J.J.; Wang, A.; Guo, W.; Keay, J.C.; Mishima, T.D.;
Johnson, M.B.; Peng, X. J. Am. Chem. Soc. 2003, 125, 1256712575.
5. http://withfriendship.com/user/mithunss/quantum-dot.php
6. http://www.observatorynano.eu/project/document/103/

